Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma
Susana Galli
, Arlene Naranjo
,
Collin Van Ryn
, Jason U. Tilan
, Emily Trinh
, Chao Yang
, Jessica Tsuei
, Sung Hyeok Hong
, Hongkun Wang
, Ewa Izycka-Swieszewska
, Yi Chien Lee
, Olga C. Rodriguez
, Chris Albanese
, Joanna Kitlinska
Biostatistics
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Therapeutic Target
100%
Neuroblastoma
100%
Neuropeptide Y
100%
Y5 Receptor
50%
Tumor
25%
Tumor Cells
25%
Receptor-mediated
25%
Immunoreactivity
25%
Neuroblastoma Cells
25%
Y2 Receptor
25%
Angioinvasive
25%
Disease Progression
12%
Pediatric
12%
Cell Proliferation
12%
Mouse Model
12%
Chemoresistance
12%
Non-invasive Biomarkers
12%
Clinical High Risk
12%
Metastasis
12%
Disease Biomarker
12%
Clinical Presentation
12%
Clinical Utility
12%
Poor Survival
12%
Putative Drug Targets
12%
Clinical Significance
12%
Tumor Tissue
12%
Heterogeneous Disease
12%
Proliferative Activity
12%
Inappropriate Treatment
12%
Malignant Neoplasms
12%
Sympathoadrenal
12%
Sympathetic Neurotransmission
12%
Disease Dissemination
12%
Angiogenic Activity
12%
Undifferentiated Tumor
12%
Neuroblastic Tumors
12%
TH-MYCN Transgenic Mouse
12%
Neuropeptide Y Receptor
12%
Medicine and Dentistry
Biological Marker
100%
Ganglioneuroblastoma
100%
Neuropeptide Y
100%
Receptor
75%
Neoplasm
25%
Tumor Cell
25%
Immunoreactivity
25%
Neuroblastoma Cell
25%
Tumor
25%
Diseases
25%
Malignant Neoplasm
12%
Pediatrics
12%
Disease Exacerbation
12%
Metastatic Carcinoma
12%
Cell Proliferation
12%
Neuropeptide Y Receptor
12%
Neuropeptide Y5 Receptor
12%
Drug Resistance
12%
Neurotransmitter
12%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Neuroblastoma
100%
Neuropeptide Y
100%
Receptor
60%
Neoplasm
40%
Diseases
20%
Mouse Model
10%
Malignant Neoplasm
10%
Disease Exacerbation
10%
Neurotransmitter
10%
Neuropeptide Y Receptor
10%
Neuropeptide Y5 Receptor
10%
Drug Resistance
10%
Neuroscience
Neuropeptide Y
100%
Neuroblastoma
100%
Receptor
60%
Cell Proliferation
10%
Neurotransmitter
10%
Neuropeptide Y5 Receptor
10%
Drug Resistance
10%
Neuropeptide Y Receptor
10%